These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10522985)

  • 1. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging.
    Russell-Aulet M; Jaffe CA; Demott-Friberg R; Barkan AL
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3490-7. PubMed ID: 10522985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantification of hypothalamic GH-releasing hormone output in women: evidence for sexual dimorphism in the mechanism of the somatopause.
    Orrego JJ; Russell-Aulet M; Demott-Friberg R; Barkan AL
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5485-90. PubMed ID: 11701726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.
    Ocampo-Lim B; Guo W; DeMott-Friberg R; Barkan AL; Jaffe CA
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4396-9. PubMed ID: 8954048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological testosterone replenishment in healthy elderly men does not normalize pituitary growth hormone output: evidence against the connection between senile hypogonadism and somatopause.
    Orrego JJ; Dimaraki E; Symons K; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3255-60. PubMed ID: 15240600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
    degli Uberti EC; Ambrosio MR; Cella SG; Margutti AR; Trasforini G; Rigamonti AE; Petrone E; Müller EE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men.
    Jessup SK; Dimaraki EV; Symons KV; Barkan AL
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4776-80. PubMed ID: 14557454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.
    Pavlov EP; Harman SM; Merriam GR; Gelato MC; Blackman MR
    J Clin Endocrinol Metab; 1986 Mar; 62(3):595-600. PubMed ID: 3080468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.
    Jaffe CA; DeMott-Friberg R; Frohman LA; Barkan AL
    J Clin Endocrinol Metab; 1997 Feb; 82(2):634-7. PubMed ID: 9024267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of adenylyl cyclase-coupled growth hormone-releasing hormone (GHRH) pituitary receptors in different conditions of GHRH deprivation.
    Qing Y; Parenti M; Guzzi F; Ceresoli G; Müller EE; Cocchi D
    Brain Res; 1994 Apr; 644(1):13-8. PubMed ID: 8032940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.